2.5 mg compounded semaglutide / Cyanocobalamin Injection Compounded SEMAGLUTIDE 5MG - Lyophilized

Both medications are once-weekly injections that activate GLP-1 and GIP receptors, helping regulate blood sugar, reduce appetite, and support weight loss

Brain 146 (6), 22752284

Liraglutida (Saxenda para manejo de peso): Se inicia con 0.6 mg diarios, aumentando semanalmente (0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg) hasta alcanzar la dosis de mantenimiento de 3.0 mg diarios

The triple receptor activity of retatrutide, targeting GLP-1, GIP, and glucagon receptors simultaneously, also contributes to sustained metabolic effects beyond what the half-life alone would predict

RESEARCH DESIGN AND METHODS We analyzed data, reported with SDs, from 14 patients with FPLD (aged 58 12 years